1. From the Divisions of Clinical Pharmacology (D.G.H.) and Nephrology (A.X.G.), University of Western Ontario, London, Ontario, Canada; Stroke Prevention and Atherosclerosis Research Centre (J.D.S.), London, Ontario, Canada; and the Division of Nephrology and Hypertension (S.C.T.), Mayo Clinic College of Medicine, Rochester, Minn.